Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 7, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions
Cutaneous Leishmaniasis
Interventions
DRUG

Ciprofloxacin (BAYO9867)

Intralesional ciprofloxacin (2 mg/ml, 100 ml, Ciproxin®, Bayer Schering pharma AG, Germany), each lesion was injected based on lesion size (2 mg/cm2).

DRUG

sodium stibogluconate (Pentostam)

Intralesional sodium stibogluconate (100 mg/ml, 100 ml vial, Pentostam®, GlaxoSmithKline, UK), each lesion was injected based on lesion size (1 mg/cm2)

Trial Locations (1)

10047

RECRUITING

Mustansiriyah University, Baghdad

All Listed Sponsors
collaborator

Al-Mustansiriyah University

OTHER

lead

Al-Mustafa University College

OTHER